Related Experiment Videos
Anaphylactic-like reactions to zomepirac
Drug Intelligence & Clinical Pharmacy
|July 1, 1982
Summary
Anaphylactic reactions to zomepirac, a nonsteroidal anti-inflammatory drug (NSAID), were reported in two patients. Initial NSAID exposure may not predict severe allergic reactions upon subsequent exposure.
Area of Science:
- Immunology
- Pharmacology
- Clinical Medicine
Background:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used for pain and inflammation management.
- Anaphylaxis is a severe, potentially life-threatening allergic reaction.
- Previous studies have documented anaphylaxis to various NSAIDs.
Observation:
- Two cases of anaphylactic reactions following zomepirac administration are presented.
- Patients experienced severe allergic responses upon exposure to zomepirac.
- The reactions occurred despite potentially uneventful prior NSAID exposure.
Findings:
- Zomepirac can induce anaphylaxis in susceptible individuals.
- Cross-reactivity or varying sensitivity to NSAIDs may be a factor.
- The latency of sensitization to NSAIDs can be significant.
Implications:
- Clinicians should be vigilant for anaphylaxis in patients taking zomepirac and other NSAIDs.
- Further research is needed to understand the mechanisms of NSAID-induced anaphylaxis.
- Patient history of NSAID tolerance requires careful consideration in managing allergic risks.